Effects of methyl-group acceptors on the regulation of plasma cholesterol level in rats fed high cholesterol diets.
The effects of methyl-group acceptors such as glycine, guanidinoacetic acid, and nicotinamide on cholesterol metabolism and phosphatidylcholine(PC) biosynthesis were investigated with rats fed a 25% casein diet containing cholesterol with or without methionine supplement. The effect of ethanolamine, an indirect methyl-group acceptor via phosphatidylethanolamine(PE) formation, was also compared with those of methyl-group acceptors. The methyl-group acceptors and ethanolamine decreased or tended to decrease plasma total cholesterol level when added to the 25% casein diet. These compounds also significantly depressed the methionine-induced enhancement of plasma cholesterol level. The activity of PE N-methyltransferase was decreased by the addition of glycine, guanidinoacetic acid, and nicotinamide, but not ethanolamine, to the reaction mixture when assayed using the postmitochondrial fraction of liver homogenate, suggesting that PE N-methyltransferase activity can be depressed by glycine N-methyltransferase, guanidinoacetic acid N-methyltransferase, and nicotinamide N-methyltransferase systems. The PE N-methyltransferase activity in liver microsomes, however, did not decrease in response to the dietary addition of methyl-group acceptors. The in vitro incorporation of [CH3-14C]methionine into PC of liver slices was also significantly inhibited by the addition of glycine and nicotinamide, but not guanidinoacetic acid and ethanolamine, to the incubation medium. It is suggested that methyl-group acceptors can decrease plasma cholesterol level at least in part through the depression of PC biosynthesis via PE N-methylation pathway, and that the mechanism for the plasma cholesterol-lowering effect of ethanolamine is different from that of methyl-group acceptors.
Sugiyama
K
K
Department of Applied Biological Chemistry, Faculty of Agriculture, Shizuoka University, Japan.
Ohishi
A
A
Siyu
H
H
Takeuchi
H
H
D000818:Animals; D001647:Bile Acids and Salts / Q000378:metabolism; D002364:Caseins / Q000008:administration & dosage; D002784:Cholesterol / Q000097:blood*; D002791:Cholesterol, Dietary / Q000008:administration & dosage* / Q000494:pharmacology; D004044:Dietary Proteins / Q000008:administration & dosage; D019856:Ethanolamine; D004983:Ethanolamines / Q000494:pharmacology; D005243:Feces; D005998:Glycine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D050356:Lipid Metabolism; D008099:Liver / Q000033:anatomy & histology / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008715:Methionine / Q000008:administration & dosage / Q000494:pharmacology; D008780:Methyltransferases / Q000378:metabolism; D008862:Microsomes, Liver / Q000201:enzymology; D009536:Niacinamide / Q000494:pharmacology*; D009929:Organ Size / Q000187:drug effects; D050918:Phosphatidylethanolamine N-Methyltransferase; D051381:Rats; D011919:Rats, Inbred Strains
D001647:Bile Acids and Salts; D002364:Caseins; D002791:Cholesterol, Dietary; D004044:Dietary Proteins; D004983:Ethanolamines; D009536:Niacinamide; D019856:Ethanolamine; D002784:Cholesterol; D008715:Methionine; D008780:Methyltransferases; D050918:Phosphatidylethanolamine N-Methyltransferase; C004946:glycocyamine; D005998:Glycine